Beleta J - Search Results

1

Design, synthesis, and biological activities of new thieno[3,2-d] pyrimidines as selective type 4 phosphodiesterase inhibitors.

Crespo MI, Pagès L, Vega A, Segarra V, López M, Doménech T, Miralpeix M, Beleta J, Ryder H, Palacios JM. Crespo MI, et al. Among authors: beleta j. J Med Chem. 1998 Oct 8;41(21):4021-35. doi: 10.1021/jm981012m. J Med Chem. 1998. PMID: 9767640

2

Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.

Fonquerna S, Miralpeix M, Pagès L, Puig C, Cardús A, Antón F, Cárdenas A, Vilella D, Aparici M, Calaf E, Prieto J, Gras J, Huerta JM, Warrellow G, Beleta J, Ryder H. Fonquerna S, et al. Among authors: beleta j. J Med Chem. 2004 Dec 2;47(25):6326-37. doi: 10.1021/jm0498203. J Med Chem. 2004. PMID: 15566302

3

Synthesis and structure-activity relationships of piperidinylpyrrolopyridine derivatives as potent and selective H1 antagonists.

Fonquerna S, Miralpeix M, Pagès L, Puig C, Cardús A, Antón F, Vilella D, Aparici M, Prieto J, Warrellow G, Beleta J, Ryder H. Fonquerna S, et al. Among authors: beleta j. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1165-7. doi: 10.1016/j.bmcl.2004.12.008. Bioorg Med Chem Lett. 2005. PMID: 15686934

4

Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).

Prat M, Fernández D, Buil MA, Crespo MI, Casals G, Ferrer M, Tort L, Castro J, Monleón JM, Gavaldà A, Miralpeix M, Ramos I, Doménech T, Vilella D, Antón F, Huerta JM, Espinosa S, López M, Sentellas S, González M, Albertí J, Segarra V, Cárdenas A, Beleta J, Ryder H. Prat M, et al. Among authors: beleta j. J Med Chem. 2009 Aug 27;52(16):5076-92. doi: 10.1021/jm900132z. J Med Chem. 2009. PMID: 19653626

5

Synthesis and biological activity of pyrido[3',2':4,5]thieno[3,2-d]pyrimidines as phosphodiesterase type 4 inhibitors.

Taltavull J, Serrat J, Gràcia J, Gavaldà A, Andrés M, Córdoba M, Miralpeix M, Vilella D, Beleta J, Ryder H, Pagès L. Taltavull J, et al. Among authors: beleta j. J Med Chem. 2010 Oct 14;53(19):6912-22. doi: 10.1021/jm100524j. J Med Chem. 2010. PMID: 20825218

6

Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.

Taltavull J, Serrat J, Gràcia J, Gavaldà A, Córdoba M, Calama E, Montero JL, Andrés M, Miralpeix M, Vilella D, Hernández B, Beleta J, Ryder H, Pagès L. Taltavull J, et al. Among authors: beleta j. Eur J Med Chem. 2011 Oct;46(10):4946-56. doi: 10.1016/j.ejmech.2011.07.054. Epub 2011 Aug 5. Eur J Med Chem. 2011. PMID: 21871695

7

Second messenger systems as targets for new therapeutic agents: focus on selective phosphodiesterase inhibitors.

Palacios JM, Beleta J, Segarra V. Palacios JM, et al. Among authors: beleta j. Farmaco. 1995 Dec;50(12):819-27. Farmaco. 1995. PMID: 8634072 Review.

8

Novel heterocyclic-fused pyridazinones as potent and selective phosphodiesterase IV inhibitors.

Dal Piaz V, Giovannoni MP, Castellana C, Palacios JM, Beleta J, Doménech T, Segarra V. Dal Piaz V, et al. Among authors: beleta j. J Med Chem. 1997 May 9;40(10):1417-21. doi: 10.1021/jm970105l. J Med Chem. 1997. PMID: 9154964

9

Inhibition of eotaxin-mediated human eosinophil activation and migration by the selective cyclic nucleotide phosphodiesterase type 4 inhibitor rolipram.

Santamaria LF, Palacios JM, Beleta J. Santamaria LF, et al. Among authors: beleta j. Br J Pharmacol. 1997 Jul;121(6):1150-4. doi: 10.1038/sj.bjp.0701243. Br J Pharmacol. 1997. PMID: 9249251 Free PMC article.

10

Phosphodiesterase inhibitory properties of losartan. Design and synthesis of new lead compounds.

Segarra V, Crespo MI, Pujol F, Beleta J, Doménech T, Miralpeix M, Palacios JM, Castro A, Martinez A. Segarra V, et al. Among authors: beleta j. Bioorg Med Chem Lett. 1998 Mar 3;8(5):505-10. doi: 10.1016/s0960-894x(98)00058-4. Bioorg Med Chem Lett. 1998. PMID: 9871607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters